Radiotherapy for bone metastases

Clinical Oncology

Volumn 13, Issue 2, 2001, Pages 88-90

  Hoskin, P J ^a   Yarnold, J R ^b   Roos, D R ^c   Bentzen, S ^d  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d Gray Laboratory Research Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; RADIOISOTOPE; STRONTIUM 89;

ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FRACTURE; HUMAN; LONG BONE; MACROPHAGE; OSTEOCLAST; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; RADIOSENSITIVITY; SPINAL CORD COMPRESSION; TUMOR GROWTH;

EID: 0035028321     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9225     Document Type: Article

References (26)

1. Bates T. A review of local therapy in the treatment of bone metastases and cord compression. Int J Radiat Oncol Biol Phys 1992;23:217-21.
2. Cole DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol 1989;1:59-62.
3. Madsen EL. Painful bone metastasis: efficacy of radiotherapy assessed by the patient: a randomized trial comparing 6 Gy x 6 vs 10 Gy x 2. Int J Radiat Oncol Biol Phys 1983;9:1775-9.
4. Okawa T, Kita M, Goto M, et al. Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases. Radiother Oncol 1988;13:99-104.
5. Price P, Hoskin PJ, Easton D, et al. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986;6:247-55.
6. Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 1985;55:1468-72.
7. Tong D, Gillick L, Hendrickson F. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-9.
8. Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999;52:111-21.
9. Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997;45:109-16.
10. Hoskin PJ, Price P, Easton D, et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 1992;23:74-8.
11. Jeremic B, Shibamoto Y, Acimovic LJ, et al. A randomised trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 1998;42:161-7.
12. Nielsen OS, Bentzen SM, Sandberg E, et al. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 1998;47:233-40.
13. Niewald M, Tkocz H-J, Abel U, et al. Rapid course radiation therapy vs more standard treatment: a randomised trial for bone metastases. Int J Radiat Oncol Biol Phys 1996;36:1085-9.
14. Rasmusson B, Vejborg I, Jensen AB, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol 1995;34:179-84.
15. Steenland J, Leer J, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-9.
16. US Department of Human Services. Agency for Health Care Policy and Research. Acute pain management. Rockville MD: The Agency, 1993, Clinical Practice Guideline No. 1.
17. Barton RG, Robinson GJ, Gutierrez E, et al. Palliative radiotherapy for vertebral metastases: what are we really treating? [abstract] Clin Oncol 2000;12:328.
18. Ratanatharathorn V, Powers WE, Moss WT, et al. Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 1999;44:1-18.
19. Bentzen SM, Hoskin P, Roos D, et al. Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or ...? Int J Radiat Oncol Biol Phys 2000;46:681-3.
20. Grossman SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991;6:53-7.
21. Roos DE, O'Brien PC, Smith JG, et al. A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans Tasman Radiation Oncology Group, TROG 96.05). Int J Radiat Oncol Biol Phys 2000;46:975-81.
22. Lewington VJ, McEwan AJ, Ackery DM, et al. A prospective randomized double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991;27:954-8.
23. Porter AT, McEwan AJB, Powe JE, et al. Results of a randomized Phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1993;25:805-13.
24. Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994;31:33-40.
25. Papatheofanis FJ. Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of bone metastases. Br J Radiol 1997;70:594-8.
26. Hoskin PJ, Stratford MRL, Folkes LK. Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet 2000;355:1428-9.